Literature DB >> 23817234

A wake-up call for hibernating tumour cells.

Sara M Weis, David A Cheresh.   

Abstract

Disseminated tumour cells (DTCs) can adopt a state of long-term dormancy. However, when and why they emerge from quiescence has remained unclear. Distinct microvascular niches are now shown to regulate this process. Mature blood vessels produce signals that sustain tumour cell quiescence, whereas sprouting microvasculature provides stimuli that reactivate DTCs, leading to metastatic relapse.

Entities:  

Mesh：

Year:  2013        PMID： 23817234     DOI： 10.1038/ncb2794

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


  11 in total

Review 1.  Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 2.  Switch to the angiogenic phenotype during tumorigenesis.

Authors:  J Folkman; D Hanahan
Journal:  Princess Takamatsu Symp       Date:  1991

Review 3.  Disseminated and circulating tumor cells: Role in effective cancer management.

Authors:  Henry Lin; Marija Balic; Siyang Zheng; Ram Datar; Richard J Cote
Journal:  Crit Rev Oncol Hematol       Date:  2010-05-31       Impact factor: 6.312

Review 4.  Circulating and disseminated tumor cells in the management of breast cancer.

Authors:  Jeffrey S Ross; Elzbieta A Slodkowska
Journal:  Am J Clin Pathol       Date:  2009-08       Impact factor: 2.493

Review 5.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

6.  ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1.

Authors:  Inbal Avraham-Davidi; Yona Ely; Van N Pham; Daniel Castranova; Moshe Grunspan; Guy Malkinson; Liron Gibbs-Bar; Oded Mayseless; Gabriella Allmog; Brigid Lo; Carmen M Warren; Tom T Chen; Josette Ungos; Kameha Kidd; Kenna Shaw; Ilana Rogachev; Wuzhou Wan; Philip M Murphy; Steven A Farber; Liran Carmel; Gregory S Shelness; M Luisa Iruela-Arispe; Brant M Weinstein; Karina Yaniv
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

Review 7.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

8.  Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

Authors:  D L Weinstat-Saslow; V S Zabrenetzky; K VanHoutte; W A Frazier; D D Roberts; P S Steeg
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

Review 9.  The metastatic niche and stromal progression.

Authors:  Jonathan P Sleeman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824
View more
  5 in total

Review 1.  Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients.

Authors:  Klaus Pantel; Catherine Alix-Panabières
Journal:  Bonekey Rep       Date:  2014-11-19

Review 2.  Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.

Authors:  Laetitia Seguin; Jay S Desgrosellier; Sara M Weis; David A Cheresh
Journal:  Trends Cell Biol       Date:  2015-01-05       Impact factor: 20.808

3.  A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis.

Authors:  Sinan Uğur Umu; Hilde Langseth; Andreas Keller; Eckart Meese; Åslaug Helland; Robert Lyle; Trine B Rounge
Journal:  Mol Oncol       Date:  2020-01-10       Impact factor: 6.603

4.  Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review.

Authors:  Yinying Wu; Yangwei Fan; Danfeng Dong; Xuyuan Dong; Yuan Hu; Yu Shi; Jiayu Jing; Enxiao Li
Journal:  Ther Adv Med Oncol       Date:  2020-07-15       Impact factor: 8.168

Review 5.  Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property?

Authors:  Aline Antoniou; Aline Hébrant; Genevieve Dom; Jacques E Dumont; Carine Maenhaut
Journal:  Cell Cycle       Date:  2013-11-22       Impact factor: 4.534
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.